ODDB.org: Open Drug Database

Sanofi-Aventis (Suisse) SA - Kevzara 150 mg/1.14 ml, solution pour injection en seringue pré-remplie

Swissmedic Registration	66424	Sequence	01
Product name	Kevzara 150 mg/1.14 ml	Description	solution pour injection en seringue pré-remplie
ATC-Classification	L04AC14	ATC-Description	Sarilumab
Introduction of Sequence	20.04.2018

Composition

sarilumabum 150 mg, histidinum aut histidini hydrochloridum monohydricum, arginini hydrochloridum, saccharum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 1.14 ml.

Packungsbestandteile

Galenic Form

solution pour injection en seringue pré-remplie

Excipiens

Active Agent	Dose
Sarilumabum	150mg / 1.14ml

BAG: Active Agent	Dose
Sarilumabum	150 mg

Inactive agents
Arginine Hydrochloride
Histidinum aut Histidini Hydrochloridum Monohydricum
Polysorbatum 20
Saccharum

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
001	2	959.37	1059.80	B	SL	Yes

2025	©ywesee GmbH